NorthWest Biotherapeutics Inc (NWBO)

[koman]

Now I think I know why the NWBO- UPENN collaboration on Ovarian cancer evaporated. Dr. George Coukos who headed the pI trial in Ovarian Cancer using DCVAX-L and was supposed to do a pII trial left UPENN to head up a lab in EU. REading some of his work makes me list him as one who understands the direction and potential of immunotherapy for the next 10yrs. It would have been nice if he had produced a paper on that pI study but I havn't found it yet. I'm assuming if there was some significant results it would have been published but just as I expected that dc vaccines by itself will have a limited response using Recist criteria for measuring ORR he probably found that to be true as well.

Regarding the Direct trial news this wkend, it would be great if Dr. Bosch will present any ORR data even SD along w/ time to progression results and maybe some %survival at various time points for the entire cohort of patients for each indication. No more individual case reports unless they are new ones and not just the same old ones (or at least updated data on those four case reports.)